StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
CRISPR Therapeutics AG
NasdaqGM:CRSP
Sector
Industries
Location
Market Cap
USD 5.71 B
Share Price
USD 66.06
Avg Daily Volume
2,587,653
Change (1 day)
-3.05%
Change (1 year)
19.26%
Change (YTD)
67.84%
CRISPR Therapeutics AG Short-Term Debt for the year ending December 31, 2024: USD 17.29 M
CRISPR Therapeutics AG Short-Term Debt is USD 17.29 M for the year ending December 31, 2024, a -60.36% change year over year. Short-term debt are debt obligations that are due within one year.
-
CRISPR Therapeutics AG Short-Term Debt for the year ending December 31, 2023 was USD 43.61 M, a 37.65% change year over year.
-
CRISPR Therapeutics AG Short-Term Debt for the year ending December 31, 2022 was USD 31.68 M, a 30.30% change year over year.
-
CRISPR Therapeutics AG Short-Term Debt for the year ending December 31, 2021 was USD 24.32 M, a 7.01% change year over year.
-
CRISPR Therapeutics AG Short-Term Debt for the year ending December 31, 2020 was USD 22.72 M, a 33.84% change year over year.
Competitors
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Novo Nordisk A/S
USD 70.34
NOVO-B.CO
+0.69
0.98%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Novartis AG
USD 117.50
NOVN.SW
+0.23
0.19%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Abbott Laboratories
USD 125.64
ABT
-0.19
-0.15%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Thermo Fisher Scientific Inc.
USD 475.03
TMO
+8.32
1.78%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Boston Scientific Corporation
USD 106.21
BSX
-1.55
-1.44%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Vertex Pharmaceuticals Incorporated
USD 472.27
VRTX
-4.68
-0.98%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
CSL Limited
USD 177.62
CSL.AX
+2.36
1.34%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Siemens Healthineers AG
USD 56.26
SHL.DE
+1.52
2.77%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%
Key Data
| Date | Short-Term Debt | Long-Term Debt | Total Liabilities | Shareholders' Equity |
|---|
Competitors
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Novo Nordisk A/S
USD 70.34
NOVO-B.CO
+0.69
0.98%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
Novartis AG
USD 117.50
NOVN.SW
+0.23
0.19%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Abbott Laboratories
USD 125.64
ABT
-0.19
-0.15%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Thermo Fisher Scientific Inc.
USD 475.03
TMO
+8.32
1.78%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Boston Scientific Corporation
USD 106.21
BSX
-1.55
-1.44%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Vertex Pharmaceuticals Incorporated
USD 472.27
VRTX
-4.68
-0.98%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
CSL Limited
USD 177.62
CSL.AX
+2.36
1.34%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Siemens Healthineers AG
USD 56.26
SHL.DE
+1.52
2.77%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%